Hospitals & Healthcare Pressreleases

This section covers the managerial aspects in the Healthcare industry.

Albireo Announces Initiation of a Phase II Trial for A4250, the Company's Lead Compound for Cholestatic Liver Diseases and NASH

Thursday, February 05, 2015

Albireo today announced initiation of a phase II trial with A4250 the company39s lead compound for cholestatic liver diseases and NASH A4250 acts locally in the gut to inhibit the ileal sodium dependent bile acid transporter IBAT also referred to as ASBT The phase II study which is a crossover study..

Acute Care Medical Center Names 3t Systems Technology Partner

Wednesday, February 04, 2015

El Centro Regional Medical Center ECRMC a cityowned acutecare medical center has selected 3t Systems as their new healthcare technology partner engaging in a multimillionmultiyear contract agreement ECRMC located approximately 115 miles east of San Diego is a 161 bed medical center with several con..

IRIDEX receives FDA Clearance for Cyclo G6™ Laser System for the Treatment of Multiple Stages of Glaucoma

Tuesday, February 03, 2015

IRIDEX Corporation today announced that it has received clearance from the US Food and Drug Administration FDA to market its first laser system designed solely for use in treating glaucoma and its symptoms Specifically the Company was granted 510k clearance for the IRIDEX Cyclo G6 Laser System with ..

Dr. Harold Lancer introduces use of New PicoWay Laser, a Breakthrough Technology that Transforms Skin Texture

Tuesday, February 03, 2015

Dr Harold Lancer always at the forefront of emerging technology in medical aesthetic devices introduces his use of PicoWay a new ultrafast laser with multiple applications reflecting the doctor39s own revolutionary approach to skin care PicoWay was originally designed for the removal of multicolor ..

Nason Hospital and LifePoint Hospitals Finalize Acquisition

Monday, February 02, 2015

LifePoint Hospitals a leading hospital company focused on providing quality healthcare services close to home and the Nason Hospital Board of Directors today announced that the acquisition of Nason Hospital by LifePoint has been completed As part of the acquisition Nason Hospital has become part of..

Merck Repatriates Diabetes and Thyroids Portfolio in Russia to Continue to Drive Emerging Markets Strategy

Monday, February 02, 2015

Merck a leading company for innovative and topquality hightech products in healthcare life science and performance materials today announced the repatriation of all responsibility for its diabetes and thyroid brands in Russia back to the company The move effective as of January 1 2015 transfers all ..